Table 2.

Automatically Segmented Mean Sattler's and Haller's Layer Thickness Across the Early Treatment Diabetic Retinopathy Study Grid Subfields (Mean ± SD, Median)

AMD Severities
	Sattler's Layer			Haller's Layer
	Nonneovascular With RPD	Neovascular With RPD	Neovascular With No RPD	Nonneovascular With RPD	Neovascular With RPD	Neovascular With No RPD
Central submacular*†	25 ± 33, 8	12 ± 17, 6	59 ± 47, 48	73 ± 28, 80	64 ± 25, 54	130 ± 57, 121
Superior inner	26 ± 35, 8	11 ± 17, 8	50 ± 49, 35	81 ± 39, 60	70 ± 49, 52	119 ± 67, 104
Temporal inner†	21 ± 28, 7	11 ± 18, 6	49 ± 51, 27	79 ± 36, 63	61 ± 26, 53	115 ± 61, 100
Inferior inner*†	23 ± 36, 7	12 ± 20, 4	68 ± 48, 48	74 ± 34, 61	59 ± 19, 51	135 ± 64, 139
Nasal inner†	26 ± 33, 11	14 ± 21, 6	57 ± 46, 53	75 ± 37, 56	64 ± 29, 54	131 ± 62, 150
Superior outer	21 ± 25, 10	8 ± 7, 5	36 ± 35, 21	79 ± 37, 61	67 ± 37, 55	111 ± 66, 96
Temporal outer	16 ± 22, 5	8 ± 7, 6	29 ± 30, 12	73 ± 31, 57	60 ± 22, 50	103 ± 68, 80
Inferior outer*†	15 ± 20, 8	8 ± 9, 4	48 ± 37, 56	69 ± 27, 59	63 ± 22, 51	118 ± 55, 119
Nasal outer†	19 ± 25, 8	12 ± 16, 6	42 ± 31, 46	69 ± 28, 56	63 ± 29, 50	118 ± 53, 137

Data are expressed as mean ± SD in micrometers.

^*P < 0.05, Kruskal-Wallis test, when compared between the disease groups for each sublayer.

^†P < 0.05 with a significant difference between the neovascular group without RPD and the other groups with RPD (one-way ANOVA, post hoc P < 0.05).